Sandra Demaria

Mar 6, 2024 | jamanetwork.com | Lisa Newman |Rachel Martini |Sandra Demaria |Silvia C. Formenti

Population-based breast cancer mortality rates are 40% higher in Black women than White women.1 This disparity is partly explained by Black women having a 2-fold higher incidence of tumors negative for expression of estrogen receptor, progesterone receptor, and ERBB2, ie, triple-negative breast cancer (TNBC).1 Advances in cancer genomics have generated insights regarding immunotherapeutics in breast cancer.